Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've searched for how to mix semaglutide 5mg and bacteriostatic water, it's worth pausing on something important: licensed Wegovy comes pre-filled, pre-measured and ready to inject — no mixing, no vials, no syringes required. The mixing question itself is a signal that the product in front of you may not be the licensed medicine. This page explains what that means for your safety, and what the legal route to semaglutide in the UK actually looks like.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy, the brand of semaglutide licensed in the UK for weight management, is manufactured as a ready-to-use solution inside a pre-filled pen. There is no powder inside, no separate vial of bacteriostatic water, and no calculation to do before injecting. Novo Nordisk engineers the formulation so that the active ingredient is stable in liquid form throughout the pen's shelf life, provided it is stored correctly (refrigerated, away from direct light, as the patient information leaflet specifies).
This matters because reconstitution (dissolving a powder in a diluent) is a pharmaceutical process that happens under controlled conditions. When it happens at home, with equipment sourced informally, sterility cannot be guaranteed, concentration cannot be verified, and the dose drawn into a syringe is a manual calculation with real room for error. These are not theoretical concerns. They are the reasons the MHRA requires medicines like semaglutide to go through clinical assessment and licensed supply before reaching patients.
The NHS medicines page for semaglutide describes the licensed product straightforwardly: a solution, in a pre-filled injector pen, prescribed and dispensed through regulated channels. Vials and bacteriostatic water do not appear, because they are not part of that product. If you are looking at something different, the product itself is telling you something worth hearing.
It can feel frustrating to read a safety warning when you've already spent money on a product and just want to use it safely. That frustration is understandable, and it is exactly why being direct here matters more than being gentle.
The MHRA has published repeated warnings about fake and unlicensed weight-loss injectables sold online and through social media. In one enforcement operation in October 2025, a UK manufacturing site producing counterfeit tirzepatide pens was raided in Northampton. Across 2025, around 20 million doses of illegally traded weight-loss medicines (with an estimated street value of roughly £45 million) were seized. Earlier investigations found counterfeit pens labelled as semaglutide products containing insulin, a substance that, injected without a diagnosis of diabetes and without dose calibration, can cause life-threatening hypoglycaemia.
Beyond counterfeits, even genuine pharmaceutical-grade semaglutide powder sourced from a research supplier is not the same product as the licensed medicine. It has not been assessed for the same safety standards, its concentration may vary from the label, and reconstituting it at home introduces contamination risk. You can report a suspect product or seller directly through the MHRA's Yellow Card scheme, the same platform used to report side effects from licensed medicines.
For context on what licensed semaglutide dosing actually looks like, the Wegovy dose guide covers the full titration schedule from 0.25mg upward, without any reconstitution step.
Semaglutide for weight management is a prescription-only medicine under UK law. The only legal route is a prescription issued following a clinical assessment by a registered prescriber, dispensed by a GPhC-registered pharmacy through the licensed supply chain. That prescription can come via an NHS specialist weight management service or, for those who do not meet NHS criteria or prefer not to wait, through a regulated private service.
The Wegovy treatment overview covers eligibility, the titration schedule and what to expect, while the semaglutide 5mg page explains where that dose sits in the licensed progression. For anyone who has been given a vial rather than a pen, or who is unsure about the source of their current treatment, the right next step is a conversation with a prescriber rather than a mixing guide, and if you do have a vial-based product, our page on how to mix 10mg semaglutide sets out exactly what that process involves so you can understand what you are being asked to do. You can also read about what buying Wegovy legally online involves, including how to verify any online pharmacy on the GPhC register before sharing any personal or medical information.
At nume, every consultation is read by a GPhC-registered Independent Prescriber (a real clinician, not an automated system) and treatment is dispensed only through our own GPhC-registered pharmacy (registration number 9012878, verifiable at the GPhC pharmacy register). The medicine that arrives is the licensed pre-filled pen, and if you have recently moved from a vial-based product and want guidance on the device itself, our page on how to use the semaglutide 5mg pen walks through the process step by step. No mixing required.
If you'd like to understand whether you're suitable for licensed semaglutide treatment, speak to our prescribers through a free consultation, the clinical team will assess your situation properly and answer questions about switching or starting treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.